|
Cysteinyl leukotriene receptor 1, also known as CYSLT1, is a human gene.[1]
The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Pharmacologic studies have determined that cysteinyl leukotrienes activate at least 2 receptors, the protein encoded by this gene and CYSLTR2. This encoded receptor is a member of the superfamily of G protein-coupled receptors. Activation of this receptor by LTD4 results in contraction and proliferation of smooth muscle, oedema, eosinophil migration and damage to the mucus layer in the lung.[1]
See also
References
External links
Further reading
- Lynch KR, O'Neill GP, Liu Q, et al. (1999). "Characterization of the human cysteinyl leukotriene CysLT1 receptor.". Nature 399 (6738): 78993. doi:10.1038/21658. PMID 10391245.
- Sarau HM, Ames RS, Chambers J, et al. (1999). "Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.". Mol. Pharmacol. 56 (3): 65763. PMID 10462554.
- Gronert K, Martinsson-Niskanen T, Ravasi S, et al. (2001). "Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.". Am. J. Pathol. 158 (1): 39. PMID 11141472.
- Sjφstrφm M, Jakobsson PJ, Heimburger M, et al. (2001). "Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor.". Eur. J. Biochem. 268 (9): 257886. PMID 11322876.
- Mellor EA, Maekawa A, Austen KF, Boyce JA (2001). "Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells.". Proc. Natl. Acad. Sci. U.S.A. 98 (14): 79649. doi:10.1073/pnas.141221498. PMID 11438743.
- Mita H, Hasegawa M, Saito H, Akiyama K (2002). "Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils.". Clin. Exp. Allergy 31 (11): 171423. PMID 11696047.
- Shirasaki H, Kanaizumi E, Watanabe K, et al. (2003). "Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa.". Clin. Exp. Allergy 32 (7): 100712. PMID 12100046.
- Ohshima N, Nagase H, Koshino T, et al. (2002). "A functional study on CysLT(1) receptors in human eosinophils.". Int. Arch. Allergy Immunol. 129 (1): 6775. PMID 12373000.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899903. doi:10.1073/pnas.242603899. PMID 12477932.
- Ohd JF, Nielsen CK, Campbell J, et al. (2003). "Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.". Gastroenterology 124 (1): 5770. doi:10.1053/gast.2003.50011. PMID 12512030.
- Chibana K, Ishii Y, Asakura T, Fukuda T (2003). "Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin.". J. Immunol. 170 (8): 42905. PMID 12682264.
- Espinosa K, Bossι Y, Stankova J, Rola-Pleszczynski M (2003). "CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4.". J. Allergy Clin. Immunol. 111 (5): 103240. PMID 12743568.
- Walch L, Norel X, Gascard JP, Brink C (2003). "Arachidonic acid inhibits cysteinyl-leukotriene receptor activation in human pulmonary vessels.". Adv. Exp. Med. Biol. 525: 759. PMID 12751740.
- Nielsen CK, Ohd JF, Wikstrφm K, et al. (2003). "The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer.". Adv. Exp. Med. Biol. 525: 2014. PMID 12751768.
- Mechiche H, Naline E, Candenas L, et al. (2003). "Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites.". Clin. Exp. Allergy 33 (7): 88794. PMID 12859443.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 405. doi:10.1038/ng1285. PMID 14702039.
- Yang G, Haczku A, Chen H, et al. (2004). "Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4.". Am. J. Physiol. Lung Cell Mol. Physiol. 286 (5): L9921001. doi:10.1152/ajplung.00367.2003. PMID 15064240.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 21217. doi:10.1101/gr.2596504. PMID 15489334.
- Naik S, Billington CK, Pascual RM, et al. (2005). "Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling.". J. Biol. Chem. 280 (10): 872232. doi:10.1074/jbc.M413014200. PMID 15590629.
- Corrigan C, Mallett K, Ying S, et al. (2005). "Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis.". J. Allergy Clin. Immunol. 115 (2): 31622. doi:10.1016/j.jaci.2004.10.051. PMID 15696087.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|
Transmembrane receptor: G protein-coupled receptors |
|
| Class A: Rhodopsin like |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GPR ( 1, 3, 4, 6, 12, 15, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 31, 32, 33, 34, 35, 37, 39, 42, 44, 45, 50, 52, 55, 61, 62, 63, 65, 68, 75, 77, 78, 82, 83, 84, 85, 87, 88, 92, 101, 103, 119, 120, 132, 135, 139, 141, 142, 146, 148, 149, 150, 151, 152, 153, 160, 161, 162, 171, 172A, 173, 174, 176, 177, 182)
|
|
|
|
Adenosine ( A1, A2a, A2b, A3) P2Y ( 1, 2, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14)
|
|
|
|
|
|
|
Other
|
Acetylcholine ( M1, M2, M3, M4, M5) Adrenomedullin Anaphylatoxin ( C3a, C5a) Angiotensin ( 1, 2) Apelin Bile acid Bombesin ( BRS3, GRPR, NMBR) Bradykinin ( B1, B2) Cannabinoid ( CB1, CB2) Chemokine Cholecystokinin ( A, B) Dopamine ( D1, D2, D3, D4, D5) EBI2 Endothelin ( A, B) Estrogen Formyl peptide ( 1, L1, L2) Free fatty acid ( 1, 2, 3, 4) FSH Galanin ( 1, 2, 3) Gonadotropin-releasing hormone ( 1, 2) Ghrelin Histamine ( H1, H2, H3, H4) Kisspeptin Luteinizing hormone/choriogonadotropin Lysophospholipid ( 1, 2, 3, 4, 5, 6, 7, 8) MAS ( 1, 1L, D, E, F, G, X1, X2, X3, X4) Melanocortin ( 1, 2, 3, 4, 5) MCHR ( 1, 2) Melatonin ( 1A, 1B) Motilin Opioid ( Delta, Kappa, Mu, Nociceptin, but not Sigma) Olfactory Opsin ( 3, 4, 5, 1LW, 1MW, 1SW, RGR, RRH) Orexin ( 1, 2) Oxytocin Oxoglutarate PAF Prokineticin ( 1, 2) Prolactin-releasing peptide Protease-activated ( 1, 2, 3, 4) Relaxin ( 1, 2, 3, 4) Somatostatin ( 1, 2, 3, 4, 5) SREB Succinate TAAR ( 1, 2, 3, 5, 6, 8, 9) Tachykinin ( 1, 2, 3) Thyrotropin Thyrotropin-releasing hormone Urotensin-II Vasopressin ( 1A, 1B, 2)
|
|
|
| Class B: Secretin like |
|
|
GPR ( 56, 64, 97, 98, 110, 111, 112, 113, 114, 115, 116, 123, 124, 125, 126, 128, 133, 143, 144, 157)
|
|
|
Other
|
Brain-specific angiogenesis inhibitor ( 1, 2, 3) Cadherin ( 1, 2, 3) Calcitonin CALCRL CD97 Corticotropin-releasing hormone ( 1, 2) EMR ( 1, 2, 3) Glucagon ( GR, GIPR, GLP1R, GLP2R) Growth hormone releasing hormone PACAPR1 GPR Latrophilin ( 1, 2, 3, ELTD1) Parathyroid hormone ( 1, 2) Secretin Vasoactive intestinal peptide ( 1, 2)
|
|
|
Class C: Metabotropic
glutamate / pheromone |
|
|
TAS1R ( 1, 2, 3) TAS2R ( 1, 3, 4, 5, 8, 9, 10, 12, 13, 14, 16, 38, 39, 40, 41, 43, 44, 45, 46, 47, 48, 49, 50)
|
|
|
Other
|
Calcium-sensing receptor GABA B ( 1, 2) Glutamate receptor ( Metabotropic glutamate ( 1, 2, 3, 4, 5, 6, 7, 8)) GPRC6A GPR ( 156, 158, 179) RAIG ( 1, 2, 3, 4)
|
|
|
| Frizzled / Smoothened |
|
|
| |
